The use of a polygenic risk score for schizophrenia can effectively predict an antipsychotic treatment response after a first episode of psychosis.
Healthcare interventions should assess the multiple layers of a person’s life, rather than simply classifying marginalized groups as vulnerable.
Ketamine, originally approved by the FDA in 1970 as an anesthetic, is increasingly being recognized as an option in treatment-resistant depression.
Psychosis, or a psychotic episode, is characterized by a distorted perception of reality that is often exacerbated by hallucinations or delusions.
The use of ezogabine, a KCNQ channel opener, may improve depression and anhedonic symptoms in patients with major depressive disorder.
Future studies need to determine whether improvement in cognition with abstinence is associated with improvement in academic and other functional outcomes.
A recent review found that existing psychosocial interventions using cognitive-behavioral and mindfulness-based approaches had a small but significant effect on quality of life and anxiety outcomes in patients with psoriasis.
Investigators conducted a comprehensive literature review to determine whether CBT is the most effective form of psychotherapy for children with anxiety disorders.
The role of noninvasive brain stimulation of the prefrontal cortex on amygdala threat reactivity in individuals with trait anxiety was examined.
In patients with traumatic injury, there may be a benefit to starting paroxetine to prevent PTSD and associated symptoms, including numbing and avoidance.